BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 11125477)

  • 1. B cell subsets in pristane-induced autoimmunity.
    Richards HB; Reap EA; Shaw M; Satoh M; Yoshida H; Reeves WH
    Curr Top Microbiol Immunol; 2000; 252():201-7. PubMed ID: 11125477
    [No Abstract]   [Full Text] [Related]  

  • 2. Widespread susceptibility among inbred mouse strains to the induction of lupus autoantibodies by pristane.
    Satoh M; Richards HB; Shaheen VM; Yoshida H; Shaw M; Naim JO; Wooley PH; Reeves WH
    Clin Exp Immunol; 2000 Aug; 121(2):399-405. PubMed ID: 10931159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-1 cells and autoimmunity.
    Murakami M; Honjo T
    Ann N Y Acad Sci; 1995 Sep; 764():402-9. PubMed ID: 7486555
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of CD5+ B cells in the production of autoantibodies in murine systemic lupus erythematosus.
    Reap EA; Sobel ES; Cohen PL; Eisenberg RA
    Ann N Y Acad Sci; 1992 May; 651():588-90. PubMed ID: 1376085
    [No Abstract]   [Full Text] [Related]  

  • 5. CD5+ B cells as precursors of CD5- IgG anti-DNA antibody-producing B cells in autoimmune-prone NZB/W F1 mice.
    Kanno K; Okada T; Abe M; Hirose S; Shirai T
    Ann N Y Acad Sci; 1992 May; 651():576-8. PubMed ID: 1376080
    [No Abstract]   [Full Text] [Related]  

  • 6. X-linked immunodeficient mice spontaneously produce lupus-related anti-RNA helicase A autoantibodies, but are resistant to pristane-induced lupus.
    Satoh M; Mizutani A; Behney KM; Kuroda Y; Akaogi J; Yoshida H; Nacionales DC; Hirakata M; Ono N; Reeves WH
    Int Immunol; 2003 Sep; 15(9):1117-24. PubMed ID: 12917264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies to ribosomal P antigens with immune complex glomerulonephritis in SJL mice treated with pristane.
    Satoh M; Hamilton KJ; Ajmani AK; Dong X; Wang J; Kanwar YS; Reeves WH
    J Immunol; 1996 Oct; 157(7):3200-6. PubMed ID: 8816434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on experimental systemic lupus erythematosus mouse model induced by pristane].
    Li JZ; Ding J; Merim B; Li HW; Zhang Y; Shen H; Chen XJ; Wang SJ; Wang Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Feb; 27(2):119-22. PubMed ID: 21315035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinoic Acid Exerts Disease Stage-Dependent Effects on Pristane-Induced Lupus.
    Abdelhamid L; Cabana-Puig X; Swartwout B; Lee J; Li S; Sun S; Li Y; Ross AC; Cecere TE; LeRoith T; Werre SR; Wang H; Reilly CM; Luo XM
    Front Immunol; 2020; 11():408. PubMed ID: 32265909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pristane-induced autoimmunity in germ-free mice.
    Mizutani A; Shaheen VM; Yoshida H; Akaogi J; Kuroda Y; Nacionales DC; Yamasaki Y; Hirakata M; Ono N; Reeves WH; Satoh M
    Clin Immunol; 2005 Feb; 114(2):110-8. PubMed ID: 15639644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue-specific expansion of NKT and CD5+B cells at the onset of autoimmune disease in (NZBxNZW)F1 mice.
    Morshed SR; Mannoor K; Halder RC; Kawamura H; Bannai M; Sekikawa H; Watanabe H; Abo T
    Eur J Immunol; 2002 Sep; 32(9):2551-61. PubMed ID: 12207339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmunity develops in lupus-prone NZB mice despite normal T cell tolerance.
    Wither J; Vukusic B
    J Immunol; 1998 Nov; 161(9):4555-62. PubMed ID: 9794382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maintenance of autoantibody production in pristane-induced murine lupus.
    Han S; Zhuang H; Xu Y; Lee P; Li Y; Wilson JC; Vidal O; Choi HS; Sun Y; Yang LJ; Reeves WH
    Arthritis Res Ther; 2015 Dec; 17():384. PubMed ID: 26717913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disparate T cell requirements of two subsets of lupus-specific autoantibodies in pristane-treated mice.
    Richards HB; Satoh M; Jennette JC; Okano T; Kanwar YS; Reeves WH
    Clin Exp Immunol; 1999 Mar; 115(3):547-53. PubMed ID: 10193432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD5 B cells in autoimmunity.
    Talal N; Dauphinee M; Ahmed SA
    Ann N Y Acad Sci; 1992 May; 651():551-6. PubMed ID: 1376075
    [No Abstract]   [Full Text] [Related]  

  • 16. Caspase-1 is required for maintenance of marginal zone B cells in pristane-induced lupus.
    Morse MD; Clark KL; Cascalho M; Kahlenberg JM
    Lupus; 2016 Jan; 25(1):81-7. PubMed ID: 26405027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unconventional NK1.1(-) intermediate TCR cells as major T lymphocytes expanding in chronic graft-versus-host disease.
    Miyakawa R; Miyaji C; Watanabe H; Yokoyama H; Tsukada C; Asakura H; Abo T
    Eur J Immunol; 2002 Sep; 32(9):2521-31. PubMed ID: 12207336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Both splenic CD5(+) B and CD5(-) B cells produce platelet glycoprotein-specific autoantibodies in chronic ITP.
    Hou M; Lv B; He Q; Lu L; Shi Y; Ji X; Ma D; Zhang M
    Thromb Res; 2003 Apr; 110(1):1-5. PubMed ID: 12877901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depletion of peritoneal CD5+ B cells has no effect on the course of Leishmania major infection in susceptible and resistant mice.
    Babai B; Louzir H; Cazenave PA; Dellagi K
    Clin Exp Immunol; 1999 Jul; 117(1):123-9. PubMed ID: 10403925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmune syndrome after neonatal induction of tolerance to alloantigens: analysis of the specificity and of the cellular and genetic origin of autoantibodies.
    Schurmans S; Merino J; Qin HY; Kramar G; Duchosal M; Skalli O; Benzonana G; Gabbiani G; Lambert PH
    Autoimmunity; 1991; 9(4):283-91. PubMed ID: 1720028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.